TY - JOUR
T1 - Pulmonary involvement in Niemann-Pick C type 1
AU - Staretz-Chacham, Orna
AU - Aviram, M.
AU - Morag, I.
AU - Goldbart, A.
AU - Hershkovitz, E.
N1 - Publisher Copyright:
© 2018, Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2018/11/1
Y1 - 2018/11/1
N2 - Niemann-Pick disease type C (NPC) is a lysosomal storage disorder caused by mutations in either NPC-1 or NPC-2 genes, resulting in abnormal intracellular cholesterol trafficking. The estimated prevalence of NPC disease is 1: 120,000–150,000. Lung involvement has been described in only few patients with NPC, mostly NPC2. We describe a series of 12 patients, originating from six families all homozygotes to the p.R404Q (c.1211G > A) mutation of NPC1 gene; nine of them had significant pulmonary manifestations. All patients were followed in our medical center. Nine of the patients had pulmonary involvement, with recurrent pneumonia as the first manifestation in most, followed by recurrent wheezing episodes and subsequent development of interstitial lung disease with chronic need for oxygen support. Seven patients were reported of having interstitial disease by various imaging modalities. Conclusion: Pulmonary involvement in NPC1 is more common than previously reported. It is characterized as primary obstructive and restrictive lung disease and not only as part of neurologic sequel of NPC. It can lead to respiratory insufficiency and death from respiratory failure.What is Known:• Lung involvement has been described in only few patients with NPC.• Most reported NPC cases with pulmonary involvement were of NPC2.What is New:• Pulmonary involvement in NPC1 is more common than previously reported.• Pulmonary involvement in NPC1 should be considered as part of the disease and be thoroughly assessed and managed.
AB - Niemann-Pick disease type C (NPC) is a lysosomal storage disorder caused by mutations in either NPC-1 or NPC-2 genes, resulting in abnormal intracellular cholesterol trafficking. The estimated prevalence of NPC disease is 1: 120,000–150,000. Lung involvement has been described in only few patients with NPC, mostly NPC2. We describe a series of 12 patients, originating from six families all homozygotes to the p.R404Q (c.1211G > A) mutation of NPC1 gene; nine of them had significant pulmonary manifestations. All patients were followed in our medical center. Nine of the patients had pulmonary involvement, with recurrent pneumonia as the first manifestation in most, followed by recurrent wheezing episodes and subsequent development of interstitial lung disease with chronic need for oxygen support. Seven patients were reported of having interstitial disease by various imaging modalities. Conclusion: Pulmonary involvement in NPC1 is more common than previously reported. It is characterized as primary obstructive and restrictive lung disease and not only as part of neurologic sequel of NPC. It can lead to respiratory insufficiency and death from respiratory failure.What is Known:• Lung involvement has been described in only few patients with NPC.• Most reported NPC cases with pulmonary involvement were of NPC2.What is New:• Pulmonary involvement in NPC1 is more common than previously reported.• Pulmonary involvement in NPC1 should be considered as part of the disease and be thoroughly assessed and managed.
KW - Cholesterol trafficking
KW - Mutation R404Q
KW - Niemann-Pick C1 disease
KW - Pulmonary involvement
KW - Respiratory failure
UR - http://www.scopus.com/inward/record.url?scp=85051122512&partnerID=8YFLogxK
U2 - 10.1007/s00431-018-3219-6
DO - 10.1007/s00431-018-3219-6
M3 - Article
C2 - 30066180
AN - SCOPUS:85051122512
VL - 177
SP - 1609
EP - 1615
JO - European Journal of Pediatrics
JF - European Journal of Pediatrics
SN - 0340-6199
IS - 11
ER -